Zhejiang Rui'an People's Hospital
Welcome,         Profile    Billing    Logout  
 2 Trials 
7 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hong, Liang
NCT06368882: Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease(OCEAN PROJECT)

Recruiting
4
1500
RoW
Peg-Interferon α, nucleo(s)tide analogue
First Affiliated Hospital of Wenzhou Medical University
Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b
12/28
12/28
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
NCT06569524: Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)

Recruiting
2
120
RoW
TQA2225/AP025 or TQA2225/AP025 Placebo 25mg, TQA2225/AP025 or TQA2225/AP025 Placebo 50mg
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Non-alcoholic Steatohepatitis
12/26
12/27
TQ-A3334-II-03, NCT06706310: Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection

Recruiting
2
116
RoW
Placebo, TQA3334 Tablet, Nucleoside (acid) analogs (NAs)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Hepatitis B
12/25
06/26
NCT05632861: HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)

Recruiting
2
76
RoW
HuHuangLianzonggan capsule, Experimental group, HuHuangLianzonggan capsule placebo, Placebo group
Tasly Pharmaceutical Group Co., Ltd
NASH
12/24
12/24
NCT05190861: Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis

Recruiting
N/A
2000
RoW
droplet digital PCR method, blood culture
Huashan Hospital
Sepsis, Septic Shock
12/22
06/23
NCT05965128: Promotion and Application of a New Three-level Etiological Diagnosis Strategy for Fever Clinics in Respiratory Infectious Diseases

Recruiting
N/A
1255
RoW
Huashan Hospital
Respiratory Infectious Diseases
12/23
12/27

Download Options